Medicine and Dentistry
Cholangiocarcinoma
100%
Organoid
60%
Phosphotransferase
60%
Patient
60%
Phosphotransferase Inhibitor
40%
Therapeutic Procedure
40%
Predictor
20%
Screening
20%
Malignant Neoplasm
20%
Inpatient
20%
Personalized Medicine
10%
Growth Factor
10%
Combination Therapy
10%
Biological Marker
10%
Drug
10%
Microarray
10%
Phosphotyrosine
10%
Chemotherapeutic Agent
10%
RNA Sequence
10%
Drug Response
10%
Cholangiocyte
10%
Hepatobiliary System
10%
Tissues
10%
Mitogen-Activated Protein Kinase
10%
Epidermal Growth Factor Receptor
10%
Nursing and Health Professions
Bile Duct Carcinoma
100%
Phosphotransferase
60%
Electric Potential
40%
Phosphotransferase Inhibitor
40%
Screening
20%
Procedures
20%
Malignant Neoplasm
20%
Donor
20%
Personalized Medicine
10%
Chemotherapy
10%
Combination Therapy
10%
Biological Marker
10%
Drug
10%
Growth Factor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Carcinoma
100%
Phosphotransferase
60%
Phosphotransferase Inhibitor
40%
Malignant Neoplasm
20%
Biological Marker
10%
Drug
10%
Phosphotyrosine
10%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Electric Potential
40%
Screening
20%
RNA Sequence
10%
Microarrays
10%
Growth Factor
10%
Drug Response
10%
Mitogen-Activated Protein Kinase
10%
Cholangiocyte
10%
Accuracy
10%
Neuroscience
Kinase
100%
Chemotherapy
10%
Phosphotyrosine
10%
RNA Sequence
10%
Growth Factor
10%